Saudi Arabia - Re-Export of Penicillins or Streptomycins Not in Dosage Forms
At $75,525.71 in 2019, the country was number 3 comparing other countries in Re-Export of Penicillins or Streptomycins Not in Dosage Forms. Saudi Arabia is overtaken by United States, which was ranked number 2 with $108,118 and is followed by United Arab Emirates at $28,682.16. New Zealand topped the ranking with $476,039.52 in 2019, a decrease of 2.3% compared to 2018. Guyana witnessed the best average annual growth at +152% per year, while United States witnessed the worst performance at -25.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 75,525.71 |
| 2018 | 205,021.02 |
| 2017 | 477,564.13 |
| 2016 | |
| 2015 | 30,615.47 |
Download all data from 1991 to 2019
How does Saudi Arabia rank in Re-Export of Penicillins or Streptomycins Not in Dosage Forms?
| # | 11 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
New Zealand
|
476,039.52 | 2019 | -2.3 % | -7.7 % | View data |
| 2 |
#2
United States
|
108,118.00 | 2019 | -33.5 % | -25.7 % | View data |
| 3 |
#3
Saudi Arabia
|
75,525.71 | 2019 | -63.2 % | NA | View data |
| 4 |
#4
United Arab Emirates
|
28,682.16 | 2019 | +139.1 % | +18.9 % | View data |
| 5 |
#5
Yemen
|
26,317.00 | 2015 | +2,726.8 % | NA | View data |